Status:
COMPLETED
Sensory and Emotional Modulation of Dyspnea Under Artificial Ventilation in the Intensive Care Unit
Lead Sponsor:
Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil
Conditions:
Dyspnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rationale: Half of the patients receiving mechanical ventilation in the intensive care unit (ICU) have moderate to severe dyspnea. This dyspnea has a negative impact on the duration of mechanical vent...
Detailed Description
Dyspnea or "shortness of breath" is a major symptom that alters the quality of life of patients who suffer from it. It is a multimodal sensation that integrates psychological, social and environmental...
Eligibility Criteria
Inclusion
- Mechanical ventilation : invasive for at least 48 hours or non-invasive for at least 24 hours, sequential or continuous
- Dyspnea ≥ 4 on a visual analogic scale (VAS) from 0 to 10
- Absence of delirium (evaluated by the CAM-ICU score) ;
- Communicative patient
Exclusion
- Patients on ECMO or decarboxylation ;
- Patients on long-term left ventricular support;
- Patients postoperatively following any surgery (pain from the procedure may interfere with dyspnea);
- Protected minors and adults;
- Pregnant women.
Key Trial Info
Start Date :
November 26 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 26 2021
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04815317
Start Date
November 26 2019
End Date
November 26 2021
Last Update
September 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Pneumologie et Réanimation Médicale, Groupe Hospitalier Pitié Salpêtrière
Paris, France, 75013